HSP90α and HSP90β isoforms selectively modulate MHC class II antigen presentation in B cells

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7451-7458

  Houlihan, Josetta L ^a,b   Metzler, Jennifer J ^c   Blum, Janice S ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c BALL STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELDANAMYCIN; GLUTAMATE DECARBOXYLASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90 ALPHA; HEAT SHOCK PROTEIN 90 BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RADICICOL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; HEAT SHOCK PROTEIN 90; HLA ANTIGEN CLASS 2; ISOPROTEIN; MACROCYCLIC LACTAM; MACROLIDE;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL STRESS; CONTROLLED STUDY; HEAT SHOCK RESPONSE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; GENETICS; IMMUNOLOGY; METABOLISM;

ANTIGEN PRESENTATION; B-LYMPHOCYTES; BENZOQUINONES; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; MACROLIDES; PROTEIN ISOFORMS; SUBSTRATE SPECIFICITY;

EID: 67649220215     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804296     Document Type: Article

References (38)

1. Mukherjee, P., A. Dani, S. Bhatia, N. Singh, A. Y. Rudensky, A. George, V. Bal, S. Mayor, and S. Rath. 2001. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J. Immunol. 167: 2632-2641.
2. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178: 27-47. (Pubitemid 23173241)
3. Wicker, L. S., S. L. Chen, G. T. Nepom, J. F. Elliott, D. C. Freed, A. Bansal, S. Zheng, A. Herman, A. Lernmark, D. M. Zaller, et al. 1996. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J. Clin. Invest. 98: 2597-2603.
4. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191: 1513-1524.
5. Lich, J. D., J. A. Jayne, D. Zhou, J. F. Elliott, and J. S. Blum. 2003. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J. Immunol. 171: 853-859.
6. Mycko, M. P., H. Cwiklinska, J. Szymanski, B. Szymanska, G. Kudla, L. Kilianek, A. Odyniec, C. F. Brosnan, and K. W. Selmaj. 2004. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J. Immunol. 172: 202-213.
7. Tobian, A. A., D. H. Canaday, W. H. Boom, and C. V. Harding. 2004. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J. Immunol. 172: 5277-5286.
8. Haug, M., C. P. Schepp, H. Kalbacher, G. E. Dannecker, and U. Holzer. 2007. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments. Eur. J. Immunol. 37: 1053-1063.
9. Tobian, A. A., D. H. Canaday, and C. V. Harding. 2004. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells. J. Immunol. 173: 5130-5137.
10. Li, Z., A. Menoret, and P. Srivastava. 2002. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol. 14: 45-51.
11. Zhou, D., P. Li, Y. Lin, J. M. Lott, A. D. Hislop, D. H. Canaday, R. R. Brutkiewicz, and J. S. Blum. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22: 571-581.
12. Bae, J., C. Mitsiades, Y. T. Tai, R. Bertheau, M. Shammas, R. B. Batchu, C. Li, L. Catley, R. Prabhala, K. C. Anderson, and N. C. Munshi. 2007. Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell. J. Immunol. 178: 7730-7737.
13. Kunisawa, J., and N. Shastri. 2006. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 24: 523-534.
14. Rajagopal, D., V. Bal, S. Mayor, A. George, and S. Rath. 2006. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules. Eur. J. Immunol. 36: 828-841.
15. Kurotaki, T., Y. Tamura, G. Ueda, J. Oura, G. Kutomi, Y. Hirohashi, H. Sahara, T. Torigoe, H. Hiratsuka, H. Sunakawa, et al. 2007. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J. Immunol. 179: 1803-1813.
16. Binder, R. J., N. E. Blachere, and P. K. Srivastava. 2001. Heat shock proteinchaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276: 17163-17171.
17. Callahan, M. K., M. Garg, and P. K. Srivastava. 2008. Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation. Proc. Natl. Acad. Sci. USA 105: 1662-1667.
18. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163-1168. (Pubitemid 28380541)
19. Harris, K. M., P. Spirito, M. S. Maron, A. G. Zenovich, F. Formisano, J. R. Lesser, S. Mackey-Bojack, W. J. Manning, J. E. Udelson, and B. J. Maron. 2006. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114: 216-225.
20. Helqvist, S., B. S. Polla, J. Johannesen, and J. Nerup. 1991. Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1β. Diabetologia 34: 150-156.
21. Qin, H. Y., J. L. Mahon, M. A. Atkinson, P. Chaturvedi, E. Lee-Chan, and B. Singh. 2003. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J. Autoimmun. 20: 237-245.
22. Roe, S. M., C. Prodromou, R. O'Brien, J. E. Ladbury, P. W. Piper, and L. H. Pearl. 1999. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42: 260-266.
23. Waza, M., H. Adachi, M. Katsuno, M. Minamiyama, C. Sang, F. Tanaka, A. Inukai, M. Doyu, and G. Sobue. 2005. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11: 1088-1095.
24. Yorgin, P. D., S. D. Hartson, A. M. Fellah, B. T. Scroggins, W. Huang, E. Katsanis, J. M. Couchman, R. L. Matts, and L. Whitesell. 2000. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases. J. Immunol. 164: 2915-2923.
25. Ryhanen, T., E. Mannermaa, N. Oksala, J. Viiri, T. Paimela, A. Salminen, M. Atalay, and K. Kaarniranta. 2008. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells. Eur. J. Pharmacol. 584: 229-236.
26. Cristau, B., P. H. Schafer, and S. K. Pierce. 1994. Heat shock enhances antigen processing and accelerates the formation of compact class II alpha beta dimers. J. Immunol. 152: 1546-1556. (Pubitemid 24075685)
27. Csermely, P., T. Schnaider, C. Soti, Z. Prohaszka, and G. Nardai. 1998. The 90-kDa molecular chaperone family: structure, function, and clinical applications: a comprehensive review. Pharmacol. Ther. 79: 129-168.
28. Sreedhar, A. S., E. Kalmar, P. Csermely, and Y. F. Shen. 2004. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett. 562: 11-15.
29. Taherian, A., P. H. Krone, and N. Ovsenek. 2008. A comparison of Hsp90α and Hsp90β interactions with cochaperones and substrates. Biochem. Cell Biol. 86: 37-45.
30. Murphy, P. J., K. C. Kanelakis, M. D. Galigniana, Y. Morishima, and W. B. Pratt. 2001. Stoichiometry, abundance, and functional significance of the hsp90/hsp70-based multiprotein chaperone machinery in reticulocyte lysate. J. Biol. Chem. 276: 30092-30098.
31. Sharp, S., and P. Workman. 2006. Inhibitors of the HSP90 molecular chaperone: current status. Adv. Cancer Res. 95: 323-348.
32. Waza, M., H. Adachi, M. Katsuno, M. Minamiyama, F. Tanaka, and G. Sobue. 2006. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). Ann. NY Acad. Sci. 1086: 21-34.
33. Dello Russo, C., P. E. Polak, P. R. Mercado, A. Spagnolo, A. Sharp, P. Murphy, A. Kamal, F. J. Burrows, L. C. Fritz, and D. L. Feinstein. 2006. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J. Neurochem. 99: 1351-1362.
34. Lernmark, A. 1996. Glutamic acid decarboxylase-gene to antigen to disease. J. Intern. Med. 240: 259-277.
35. Jun, H. S., L. Y. Khil, and J. W. Yoon. 2002. Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol. Life Sci. 59: 1892-1901.
36. Clayton, A., A. Turkes, H. Navabi, M. D. Mason, and Z. Tabi. 2005. Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 118: 3631-3638.
37. Mambula, S. S., and S. K. Calderwood. 2006. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177: 7849-7857.
38. Agarraberes, F. A., S. R. Terlecky, and J. F. Dice. 1997. An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. J. Cell Biol. 137: 825-834.